2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1730534801 MD
Verify on CMS →

PETER KALLY, MD

Ophthalmic Plastic and Reconstructive Surgery Physician in SEATTLE, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
322
Medicare Part D claims · 190 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 624
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$14.3K
35 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

PETER KALLY, MD filed 322 Medicare Part D claims in 2023 as a Ophthalmic Plastic and Reconstructive Surgery Physician in SEATTLE, Washington, prescribing 93% generic.

322
Part D claims, 2023
93%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PETER KALLY, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

322 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

PETER KALLY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about PETER KALLY, MD?

Quality data not reported

NPI registry status

Active

Issued 04/26/2016

NPI 1730534801

Primary specialty

Ophthalmic Plastic and Reconstructive Surgery Physician

Rare

291 US NPIs in this specialty

Medicare Part D claims

322 48% vs specialty avg

2023 prescription claims

Specialty avg: 624

Specialty distribution in Washington

How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among Washington providers

Washington providers

Ophthalmic Plastic and Reconstructive Surgery Physician share within Washington

1. Ophthalmic Plastic and Reconstructive Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmic Plastic and Reconstructive Surgery Physician share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Ophthalmic Plastic and Reconstructive Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ophthalmic Plastic and Reconstructive Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Ophthalmic Plastic and Reconstructive Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ophthalmic Plastic and Reconstructive Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PETER KALLY, MD is a Ophthalmic Plastic and Reconstructive Surgery Physician provider practicing in SEATTLE, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1730534801. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

PETER KALLY, MD appears in the CMS NPPES registry as a Ophthalmic Plastic and Reconstructive Surgery Physician provider holding MD credentials at 1100 9TH AVE, SEATTLE, WA, 98101, with a listed phone of (206) 341-0895. NPI 1730534801 was issued on 04/26/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KALLY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 322 prescription claims written by this provider, covering 190 Medicare beneficiaries and totaling roughly $10K in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 9.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ophthalmic Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 291 enrolled providers across 46 states and an average of 624 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1100 9TH AVE
SEATTLE, WA 98101

Provider Details

NPI 1730534801
Specialty Ophthalmic Plastic and Reconstructive Surgery Physician
Credentials MD
Gender Male
NPI Issued 04/26/2016

Hospital and facility affiliations

Facilities where PETER KALLY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

VIRGINIA MASON MEDICAL CENTER
★★★★★ 5/5
SEATTLE, WA
Acute Care Hospitals
CMS CCN: 500005

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PETER KALLY, MD. Source: openpaymentsdata.cms.gov.

Total received

$14.3K

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to PETER KALLY, MD. To verify PETER KALLY, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

PETER KALLY, MD — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 322 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

322
Total Claims
$10K
Total Drug Cost
190
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
334
Total Day Supply
3,378
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$8K
Generic Drug Cost
$3K
Opioid Claims
32 (9.9% rate)
Antibiotic Claims
15

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
0.98
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Erythromycin
Erythromycin Base
133
Diazepam
42
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
36
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
24
Ondansetron Hcl
21
Methylprednisolone
16

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmic Plastic and Reconstructive Surgery Physician Overview

How PETER KALLY, MD fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.

291
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
46
States with Ophthalmic Plastic and Reconstructive Surgery Physician
624
Avg Claims per Provider

PETER KALLY, MD's 322 claims are below the specialty average of 624.

Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as KALLY.

Compare Ophthalmic Plastic and Reconstructive Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PETER KALLY, MD's specialty?
PETER KALLY, MD specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in SEATTLE, Washington. Credentials: MD.
How much does PETER KALLY, MD prescribe under Medicare Part D?
In 2023, PETER KALLY, MD wrote 322 Medicare Part D claims totaling $10K in drug costs for 190 beneficiaries.
Where is PETER KALLY, MD located?
PETER KALLY, MD is located at 1100 9TH AVE, SEATTLE, WA, 98101. Phone: (206) 341-0895.
What is PETER KALLY, MD's NPI number?
PETER KALLY, MD's National Provider Identifier (NPI) is 1730534801, issued on 04/26/2016.
Does PETER KALLY, MD prescribe more brand-name or generic drugs?
PETER KALLY, MD's prescribing is 7% brand-name and 93% generic drugs by claim count, with $8K in brand drug costs.
Does PETER KALLY, MD prescribe opioids?
Yes, PETER KALLY, MD had 32 opioid claims in 2023 with an opioid prescribing rate of 9.9%.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US?
There are 291 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 46 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 624 Medicare Part D claims per year.
What drugs does PETER KALLY, MD prescribe most often?
Based on 2023 Medicare Part D data, PETER KALLY, MD's most frequently prescribed drugs include Erythromycin, Diazepam, Neomycin-Polymyxin-Dexameth. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PETER KALLY, MD accept Medicare?
PETER KALLY, MD appears in CMS Medicare data with 322 Part D claims and 190 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PETER KALLY, MD's credentials?
PETER KALLY, MD's NPI is 1730534801 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology